SCHEMBL1158053

SCHEMBL1158053

CC(NSc1ccccc1[N+](=O)[O-])C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.62
MAPT P10636 5/20 0.62
KDM4E B2RXH2 2/20 0.62
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
GAA P10253 3/20 0.55
NPSR1 Q6W5P4 2/20 0.50
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48
SLC6A3 Q01959 1/20 0.48
LMNA P02545 2/20 0.47
ALPG P10696 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 2/20 0.43
POLB P06746 1/20 0.42
PKM P14618 1/20 0.42
PDE7A Q13946 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1158052 1.00 ALDH1A1 (0.62) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL11756343 0.86 MAPT (0.60) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL10970028 0.85 MAPT (0.58) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL7336052 0.82 MAPT (0.70) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL7540298 0.79 MAPT (0.81) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL1158293 0.78 MAPT (0.71) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6086577 0.78 MAPT (0.57) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6086572 0.78 MAPT (0.57) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL1158294 0.78 MAPT (0.71) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL8941930 0.77 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7888417-B2 core or the layer includes a composition formed from a base polymer, a crosslink initiator, and at least one additive; additive has at least one carbon-oxygen-boron linkage, carbon in the linkage being a secondary or tertiary carbon; enhances coefficient of restitution and/or reduces compression of core ACUSHNET COMPANY (US) 2011-02-15 US disclosed
US-20080261722-A1 COMPOSITIONS FOR USE IN GOLF BALLS ACUSHNET COMPANY 2008-10-23 US disclosed
US-20080227567-A1 COMPOSITIONS FOR USE IN GOLF BALLS ACUSHNET COMPANY 2008-09-18 US disclosed
US-20080176678-A1 Compositions for Use in Golf Balls ACUSHNET COMPANY 2008-07-24 US disclosed
US-7361711-B2 Compositions for use in golf balls ACUSHNET COMPANY (US) 2008-04-22 US disclosed
US-7358309-B2 core or the layer includes a composition formed from a base polymer, a crosslink initiator, and at least one additive; additive has at least one carbon-oxygen-boron linkage, carbon in the linkage being a secondary or tertiary carbon; enhances coefficient of restitution and/or reduces compression of core ACUSHNET COMPANY (US) 2008-04-15 US disclosed
US-7358310-B2 Compositions for use in golf balls ACUSHNET COMPANY (US) 2008-04-15 US disclosed
US-7358308-B2 Compositions for use in golf balls ACUSHNET COMPANY (US) 2008-04-15 US disclosed
US-20060281586-A1 Compositions for use in golf balls JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT 2006-12-14 US disclosed
US-20060281587-A1 Compositions for use in golf balls JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT 2006-12-14 US disclosed
US-20050245652-A1 Compositions for use in golf balls JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT 2005-11-03 US disclosed
US-5104985-A Rearrangement in the presence of an alkali metal bis (tris-lower alkyl silyl)amide HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-04-14 US disclosed
EP-0193132-B1 LABDAN-DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-04-17 EP disclosed
US-4963537-A REDUCE INTRAOCULAR PRESSURE HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1990-10-16 US disclosed
US-4851397-A LOWERING INTRAOCULAR PRESSURE HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1989-07-25 US disclosed
US-4771049-A REDUCING INTRAOCULAR PRESSURE HOECHST-ROUSSEL PHARMACEUTICALS (US) 1988-09-13 US disclosed
US-4677103-A REDUCING INTRAOCULAR PRESSURE HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-06-30 US disclosed
US-4639443-A INTRAOCULAR PRESSURE REDUCTION HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-01-27 US disclosed
EP-0193132-A2 Labdan-derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1986-09-03 EP disclosed
US-4079021-A Polymeric carrier for a controlled synthesis of peptides CESKOSLOVENSKA AKADEMIE VED (CS) 1978-03-14 US disclosed